Peer Review History
| Original SubmissionMarch 17, 2022 |
|---|
|
Assessing the effectiveness of COVID-19 vaccine lotteries: A cross-state synthetic control methods approach PONE-D-22-08024 Dear Dr. Fuller, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tiago Pereira Academic Editor PLOS ONE Additional Editor Comments: I agree with the other two referees that the paper is well written and the basic statistical analysis seem to support to claims. I therefore, recommend the manuscript for publication. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript addresses the central question of whether financial-based incentives increase the attendance to vaccination programs against covid-19. To answer it, the authors analyze data retrieved from all the states that implemented lotteries to improve vaccination rates. In order to assess the effectiveness of those interventions, a synthetic control method is employed using as covariates demographic data from the U.S. Census data and vaccine hesitancy rates, which were calculated from the raw data from the U.S. Census' Week 29 Household Pulse Survey. The findings put forward in the manuscript can be summarized as follows: i) lotteries did have a positive effect; ii) no significant effect was observed on the number of second doses (as the authors explain, the reason for this resides in the very design of the lotteries); and, perhaps most surprising, iii) state partisanship was shown to have no noticeable influence on the relationship between vaccination and lottery incentives. As acknowledged in the manuscript, this is not the first study that analyzes the impact of lotteries on vaccination rates. However, the novelty here is that the evaluation is performed taking into account every state that implemented incentive programs. This approach not only provided robust evidence that lotteries can be beneficial for vaccination campaigns, but also highlighted two important facts that might have passed unnoticed in previous works: namely, the possibility that the number of administered second doses could have been improved by modifications in the incentive programs, and the fact that state partisanship did not influence the participation in the lotteries. The former could appear somewhat obvious, but the latter comes as a surprise given the inflamed polarization that has taken over the public health debate. Overall, the work is generally clearly written, concise and easy to read; the results are solid and interesting, and I do not have any major concerns. I therefore recommend the publication. Reviewer #2: As a mathematician, I do not feel comfortable reviewing this paper in terms of its implications to political policies. Even so, I was able to follow it and understand the statistical analysis. The statistical analysis performed was very basic, but supports the main argument. I recommended it to be accepted based on the statistical analysis, hoping other reviewers were able to assert the quality of its conclusions to political policies. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-22-08024 Assessing the effectiveness of COVID-19 vaccine lotteries: A cross-state synthetic control methods approach Dear Dr. Fuller: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tiago Pereira Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .